Recent Analyst Stock Rating News
The Best Trading Research Platform
For Retail Investors and Professional Trades Alike.Get Started for Free
David Low's Stock Ratings
JP Morgan Analyst
David Low is an analyst at JP Morgan. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 04/25/2025
Overall Average Return
1.83%
Smart Score
Overall Average Return Percentile
46th
| Buy Now | Get Alert | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 04/24/2025 | RMD | Buy Now | ResMed | $234.70 | 23.56% | David Low46% | $286 → $290 | Maintains | Overweight | Get Alert |
| 01/31/2025 | RMD | Buy Now | ResMed | $234.70 | 21.86% | David Low46% | $270 → $286 | Maintains | Overweight | Get Alert |
| 01/09/2024 | RMD | Buy Now | ResMed | $234.70 | -16.92% | David Low46% | $160 → $195 | Maintains | Overweight | Get Alert |
| 01/27/2023 | RMD | Buy Now | ResMed | $234.70 | 10.78% | David Low46% | $245 → $260 | Maintains | Overweight | Get Alert |
| 01/17/2023 | RMD | Buy Now | ResMed | $234.70 | 4.39% | David Low46% | → $245 | Upgrade | Neutral → Overweight | Get Alert |
| 08/12/2022 | RMD | Buy Now | ResMed | $234.70 | — | David Low46% | — | Downgrade | Overweight → Neutral | Get Alert |
| 01/24/2022 | RMD | Buy Now | ResMed | $234.70 | 15.04% | David Low46% | $260 → $270 | Upgrade | Neutral → Overweight | Get Alert |
| 07/26/2021 | RMD | Buy Now | ResMed | $234.70 | 4.81% | David Low46% | $245 → $246 | Downgrade | Overweight → Neutral | Get Alert |
| 05/21/2021 | RMD | Buy Now | ResMed | $234.70 | -6.69% | David Low46% | $206 → $219 | Upgrade | Neutral → Overweight | Get Alert |
| 04/18/2019 | RMD | Buy Now | ResMed | $234.70 | — | David Low46% | — | Upgrade | Underweight → Neutral | Get Alert |
| 01/25/2019 | RMD | Buy Now | ResMed | $234.70 | — | David Low46% | — | Downgrade | Neutral → Underweight | Get Alert |
| 10/30/2017 | RMD | Buy Now | ResMed | $234.70 | -68.9% | David Low46% | $72 → $73 | Maintains | Overweight | Get Alert |
| 01/24/2017 | RMD | Buy Now | ResMed | $234.70 | — | David Low46% | — | Upgrade | Neutral → Overweight | Get Alert |
| 09/19/2016 | RMD | Buy Now | ResMed | $234.70 | — | David Low46% | — | Downgrade | Overweight → Neutral | Get Alert |
| 06/10/2014 | RMD | Buy Now | ResMed | $234.70 | — | David Low46% | — | Upgrade | Neutral → Overweight | Get Alert |
| 02/28/2014 | RMD | Buy Now | ResMed | $234.70 | — | David Low46% | — | Downgrade | Overweight → Neutral | Get Alert |
| 04/27/2012 | RMD | Buy Now | ResMed | $234.70 | — | David Low46% | — | Upgrade | Neutral → Overweight | Get Alert |
